IPO Trending
INFINIUMSME / NSEListed
Infinium Pharmachem

Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.

DRHP
₹135 - ₹1351.84x sub
Listed Price₹141.50
Listing Gain+4.81%

IPO Schedule & Timeline

Fixed Price IPO
Open31 Mar 2023
Close05 Apr 2023
Allotment11 Apr 2023
Listing17 Apr 2023

Quota Reservation & Application Lots

Quota Reservation (% Shares)

Market Maker94,000 shares
5.01%
Nii (hni)8,70,000 shares
46.4%
Retail8,70,000 shares
46.4%
Employee41,000 shares
2.19%

Minimum Application Lots

Retail1 Lot (1,000 shares)
₹1,35,000
HNI2 Lots (2,000 shares)
₹2,70,000

Company Promoters

Mr. Sanjaykumar Viththalbhai PatelMr. Pravin Bhadabhai MadhaniMr. Mitesh Lavjibhai Chikhaliya

Company Background

Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and G...

Lead Managers & Bankers

Swastika Investmart Limited

Financial Performance

Figures in ₹ Crores
Metric Breakdown

Revenue

Latest (Mar 2020)₹3941.64 Cr
Growth-50.6%
Revenue Trend (₹ in Crores)
0.03.8k7.7k11.5kSep 2022Mar 2022Mar 2021Mar 2020
PeriodRev (Cr)PAT (Cr)AssetsDebt
Mar 20203,941.6493.402,244.60566.17
Mar 20217,115.37272.483,418.27579.47
Mar 202210,005.25610.64 5,899.951,385.01
Sep 20227,985.39551.017,075.711,614.71

Broker & Analyst Reviews

Review Not Available

Institutional broker reviews and analyst reports have not been released for this issue yet. Reviews are typically published 2 to 3 days prior to the issue opening date.

IPO Allotment & Registrar Status

Official Registrar: Bigshare Services Private Limited

Allotment Finalized
Allotment Date
11 Apr 2023
Official Status
Out / Finalized
Registrar
Bigshare Services Private Limited
Listing Date
17 Apr 2023

Official Allotment Verification Links

Official Registrar Portal
Bigshare Services Private Limited

Direct allotment verification on the official registrar portal appointed for Infinium Pharmachem. Check with PAN or Application No.

Check on Registrar Portal
Stock Exchange Portal
BSE India Investor Portal

Official Bombay Stock Exchange investor verification channel using Issue Name and PAN Number.

Check on BSE India

Allotment Schedule & Milestones

IST
1. Allotment Finalization11 Apr 2023Basis of allotment declared
2. Refund Initiation1 day post allotmentUPI / ASBA mandate unblocked
3. Demat CreditPrior to listingShares credited to CDSL/NSDL
4. Listing Date17 Apr 2023Trading commences on exchange

How to Check Infinium Pharmachem Allotment Online

1Open Portal

Click on the official registrar link or BSE portal button above.

2Select Company

Select Infinium Pharmachem from the issue drop-down list.

3Enter Details

Select PAN, Application No., or DP Client ID and type your details.

4View Allocation

Click Submit to check your allotted share count and status.

Prospectus & Official Filings

Official FilingDRHP

Allotment FAQs & Help

About Infinium Pharmachem IPO

Complete issue overview for Infinium Pharmachem (INFINIUM) IPO. The issue features an equity share price band of ₹135 per share with a minimum retail lot size of 1000 Shares (minimum application amount of ₹1,35,000). Explore live market tracking on our GMP Tracker, compare against All IPO GMP Today, or view category bidding on the Subscription Page. Verify official allotment via IPO Registrars or review participating investment bankers in our Lead Managers Directory.

Frequently Asked Questions